The global prefilled syringes market is forecasted to grow from USD 8.65 billion in 2026 to USD 14.53 billion by 2031, at a CAGR of 10.9%. Key growth drivers include the rising prevalence of chronic ...
The new device no longer requires dose conversions. The Food and Drug Administration (FDA) has approved a specific syringe for the administration of Humulin R U-500 (regular insulin [human, rDNA ...
DUBLIN--(BUSINESS WIRE)--The "Smart Syringes Market to 2027 - Global Analysis and Forecasts by Type; Application; End User and Geography" report has been added to ResearchAndMarkets.com's offering.
Alkem launches India’s first ready-to-use semaglutide syringe for diabetes and weight loss from ₹350
The launch comes as India grapples with rising diabetes and obesity cases, offering patients another treatment option ...
LONG BEACH, Calif. -- Prefilled syringes to treat macular degeneration caused larger and more frequent spikes in intraocular pressure (IOP) as compared with medication drawn from vials, a study of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results